When the tyranny of the “Magnificent Seven” ended, I always figured the money would go to the rest of tech. I also didn’t think that there would be anything left of the Mag 7 to invest in. They would all be obliterated as part of a source-of-funds move. Club name …
It was another exciting week on Wall Street as the S & P 500 and Nasdaq each closed Friday at new record highs. Incredible as that was, this week could have easily gone another way. Last Saturday, the world learned that the U.S. had entered the Israel-Iran conflict, dropping several massive …
Jim Cramer and Jeff Marks, the Club’s director of portfolio analysis, ran through all 30 holdings in the portfolio during the June Monthly Meeting on Wednesday. Here’s a rapid fire update on each stock, starting with those that Jim and Jeff said investors should consider trimming — or that the …
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: The S & P 500 was modestly lower Friday as investors mull over the latest news from the Israel-Iran conflict …
Picture scrolling through Facebook or Instagram and spotting an advertisement that feels tailor-made for you. You’re seeing Meta Platform ‘s artificial intelligence tools in action, crafting ads for its partner businesses that specifically target and attract customers based on their interests. It has also become the secret sauce behind Meta’s …
My top 10 things to watch Monday, May 19 1. Bonds are crushing stocks this morning, with the 30-year Treasury yield north of 5% and the 10-year Treasury yield topping 4.5%, in response to Moody’s downgrading its rating on U.S. sovereign debt. The S & P 500 is on track …
Bristol Myers Squibb ‘s earnings beat and rosy outlook Thursday did not resolve lingering issues for the stock. But it was enough, for now. Revenue in the first quarter, which ended March 31, dipped 6% to $11.2 billion but topped estimates of $10.7 billion, according to LSEG. Adjusted earnings per …
Danaher shares on Tuesday climbed more than 6% after the health-care company’s first-quarter results exceeded expectations — and, crucially, its guidance was left mostly intact despite an evolving economic picture. Count us among the investors breathing a sigh of relief. Revenue for the three months ended March 31 declined 1% …
Eli Lilly is tightening its grip on the lucrative weight-loss market as it moves into a new, more convenient phase that promises to broaden the appeal of its breakthrough drugs. The news Club name Lilly said its daily obesity pill was successful in a late-stage trial for Type 2 diabetes …
When the facts change, I have to change my mind, lest be caught in some sort of homegrown dogma that will hurt us all. That’s how I feel about a phrase that has withstood all sorts of markets but I fear may have finally lost its usefulness: “own it, don’t …
